Literature DB >> 6799570

Genetic control of experimental autoimmune myasthenia gravis in mice. III. Ia molecules mediate cellular immune responsiveness to acetylcholine receptors.

P Christadoss, V A Lennon, C J Krco, C S David.   

Abstract

When MHC congenic and recombinant mice are inoculated with Torpedo acetylcholine receptors (AChR) with adjuvants, the magnitude of autoantibody responses to muscle AChR and the defect of neuromuscular transmission closely parallel in vitro lymphocyte proliferative responses to Torpedo AChR. All of these responses are controlled by gene(s) at the I-A subregion of the H-2 complex. Data presented in this report confirm in back-cross mice that T lymphocyte proliferative responses to AChR are controlled by a Mendelian dominant gene linked to H-2, at the I-A subregion. Lymphocyte responses were eliminated by blocking Ia antigens on lymph node cell surfaces with appropriate anti-I-A alloantisera and by removal of adherent cells. A spontaneous mutation at the I-A subregion in the B6 strain, which resulted in structural alteration of the A beta chain of Ia, converted high responsiveness to AChR to a state of low responsiveness. These data implicate a macrophage-associated Ia molecule in induction of autoimmune responses to AchR, probably in the presentation of AChR to helper T lymphocytes that thereby help B lymphocytes to differentiate into anti-AChR antibody-forming cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6799570

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  Antigen-major histocompatibility complex-T cell receptors: inquiries into the immunological ménage à trois.

Authors:  J Klein
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

2.  Ek alpha transgene in B10 mice suppresses the development of myasthenia gravis.

Authors:  P Christadoss; C S David; M Shenoy; S Keve
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

Review 3.  Myasthenia gravis: an autoimmune response against the acetylcholine receptor.

Authors:  Y M Graus; M H De Baets
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 4.  Immunopathology of acetylcholine receptors in myasthenia gravis.

Authors:  M E Seybold; J M Lindstrom
Journal:  Springer Semin Immunopathol       Date:  1982

5.  Mapping myasthenia gravis-associated T cell epitopes on human acetylcholine receptors in HLA transgenic mice.

Authors:  Huan Yang; Elzbieta Goluszko; Chella David; David K Okita; Bianca Conti-Fine; Teh-sheng Chan; Mathilde A Poussin; Premkumar Christadoss
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

6.  Murine streptozotocin diabetes: influences of the major histocompatibility complex, genetic background and blood transfusion.

Authors:  C Weber; B Pernis; W Ting; K Rosenkrantz; K Reemtsma
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

7.  Mutation at I-A beta chain prevents experimental autoimmune myasthenia gravis.

Authors:  P Christadoss; J M Lindstrom; R W Melvold; N Talal
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

8.  A comparison of epitope repertoires associated with myasthenia gravis in humans and nonhuman hosts.

Authors:  Kerrie Vaughan; Yohan Kim; Alessandro Sette
Journal:  Autoimmune Dis       Date:  2012-12-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.